BNP Paribas Arbitrage SA Has $11,485,000 Position in Intuitive Surgical Inc. (ISRG)
BNP Paribas Arbitrage SA boosted its position in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) by 507.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,845 shares of the company’s stock after buying an additional 13,236 shares during the period. BNP Paribas Arbitrage SA’s holdings in Intuitive Surgical were worth $11,485,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Global X Management Co. LLC purchased a new stake in Intuitive Surgical during the second quarter worth about $118,000. Bartlett & Co. LLC raised its stake in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares during the period. Glenmede Trust Co. NA raised its stake in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares during the period. IFP Advisors Inc raised its stake in shares of Intuitive Surgical by 4.2% in the second quarter. IFP Advisors Inc now owns 296 shares of the company’s stock worth $196,000 after buying an additional 12 shares during the period. Finally, Thompson Davis & CO. Inc. raised its stake in shares of Intuitive Surgical by 11.6% in the second quarter. Thompson Davis & CO. Inc. now owns 327 shares of the company’s stock worth $216,000 after buying an additional 34 shares during the period. Institutional investors own 91.60% of the company’s stock.
Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) opened at 654.89 on Friday. The firm has a 50-day moving average of $683.04 and a 200 day moving average of $671.62. Intuitive Surgical Inc. has a 12 month low of $502.01 and a 12 month high of $727.25. The company has a market capitalization of $25.38 billion, a PE ratio of 35.32 and a beta of 0.55.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 18th. The company reported $6.19 EPS for the quarter, beating analysts’ consensus estimates of $5.13 by $1.06. The business earned $682.90 million during the quarter, compared to analyst estimates of $650.49 million. Intuitive Surgical had a return on equity of 15.02% and a net margin of 27.51%. During the same period in the prior year, the company posted $5.24 earnings per share. Intuitive Surgical’s revenue was up 15.8% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical Inc. will post $22.19 earnings per share for the current fiscal year.
A number of analysts recently issued reports on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “sell” rating to a “hold” rating and set a $772.00 price target for the company in a research note on Friday, July 22nd. Raymond James Financial Inc. started coverage on shares of Intuitive Surgical in a research note on Friday, August 26th. They issued an “outperform” rating for the company. Leerink Swann restated an “outperform” rating and issued a $780.00 price target on shares of Intuitive Surgical in a research note on Monday, September 19th. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research note on Tuesday, September 20th. Finally, JPMorgan Chase & Co. restated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, September 20th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Intuitive Surgical has an average rating of “Buy” and an average price target of $729.50.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 13,515 shares of the company’s stock in a transaction on Monday, November 7th. The stock was sold at an average price of $680.68, for a total value of $9,199,390.20. Following the sale, the chief executive officer now directly owns 82,880 shares in the company, valued at $56,414,758.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $688.33, for a total value of $2,064,990.00. Following the completion of the sale, the senior vice president now owns 2,331 shares in the company, valued at $1,604,497.23. The disclosure for this sale can be found here. 3.10% of the stock is owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.